Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03720860

Inflammatory Mediators of Acute Kidney Injury in Intensive Care

Prospective Studie of Inflammatory Markers in Urine, Plasma and Sputum Associated With Acute Kidney Injury

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Acute kidney injury (AKI) affects more than 50% of patients admitted to the intensive care unit. The most common underlying cause is sepsis. Severe AKI in combination with sepsis is associated with high mortality. The mechanisms for sepsis-induced AKI are largely unknown. Our hypothesis is that the inflammatory response to an infection cause collateral damage to host tissue and contributes to the development of AKI. In this study we want to investigate the presence of novel inflammatory mediators in patients with sepsis, patients subjected to major surgery (sterile inflammation) and non-inflamed patients and correlate their levels with the risk for AKI.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2018-10-25
Last updated
2026-01-12

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03720860. Inclusion in this directory is not an endorsement.

Inflammatory Mediators of Acute Kidney Injury in Intensive Care (NCT03720860) · Clinical Trials Directory